1. Home
  2. GANX vs DIT Comparison

GANX vs DIT Comparison

Compare GANX & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

HOLD

Current Price

$67.56

Market Cap

64.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
DIT
Founded
2017
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
76.8M
64.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
GANX
DIT
Price
$1.62
$67.56
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
★ 338.1K
264.0
Earning Date
05-13-2026
04-20-2026
Dividend Yield
N/A
★ 0.74%
EPS Growth
★ 31.46
N/A
EPS
N/A
★ 1.40
Revenue
$55,180.00
★ $1,392,388,157.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$48.26
Revenue Growth
N/A
★ 5.30
52 Week Low
$1.53
$59.15
52 Week High
$4.34
$122.00

Technical Indicators

Market Signals
Indicator
GANX
DIT
Relative Strength Index (RSI) 37.42 47.94
Support Level $1.57 $59.15
Resistance Level $1.85 $74.55
Average True Range (ATR) 0.09 0.53
MACD -0.01 0.39
Stochastic Oscillator 6.70 35.74

Price Performance

Historical Comparison
GANX
DIT

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: